Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Clin Cancer Res. 2012 Jun 6;18(14):3731–3736. doi: 10.1158/1078-0432.CCR-11-2859

Table 3.

Weibull nonmixture cure model regression results

Estimate (95% CI) P
Long-term survivor model (HR)
  TT1 (ref.)
  TT2 0.85 (0.48–1.49) 0.57
  TT2+ 0.50 (0.18–0.79) 0.003
  TT3 0.18 (0.10–0.31) <0.001
  Age 1.13 (0.995–1.03) 0.16
  Cytogenetic abnormalities 1.17 (1.07–2.14) 0.019
Short-term survival model (HR)
  TT1 (ref.)
  TT2 0.51 (0.88–1.53) 0.66
  TT2+ 0.72 (0.39–1.32) 0.29
  TT3 1.72 (0.90–3.29) 0.10
  Age 1.00 (0.98–1.02) 0.80
  Cytogenetic abnormalities 1.18 (0.80–1.75) 0.40